Abstract |
The potential of nontoxic recombinant B subunits of cholera toxin (rCtxB) and its close relative Escherichia coli heat-labile enterotoxin (rEtxB) to act as mucosal adjuvants for intranasal immunization with herpes simplex virus type 1 (HSV-1) glycoproteins was assessed. Doses of 10 microg of rEtxB or above with 10 microg of HSV-1 glycoproteins elicited high serum and mucosal anti-HSV-1 titers comparable with that obtained using CtxB (10 microg) with a trace (0.5 microg) of whole toxin (Ctx-CtxB). By contrast, doses of rCtxB up to 100 microg elicited only meager anti-HSV-1 responses. As for Ctx-CtxB, rEtxB resulted in a Th2-biased immune response with high immunoglobulin G1 ( IgG1)/ IgG2a antibody ratios and production of interleukin 4 (IL-4) and IL-10 as well as gamma interferon by proliferating T cells. The protective efficacy of the immune response induced using rEtxB as an adjuvant was assessed following ocular challenge of immunized and mock-immunized mice. Epithelial disease was observed in both groups, but the immunized mice recovered by day 6 whereas mock-immunized mice developed more severe corneal disease leading to stromal keratitis. In addition, a significant reduction in the incidence of lid disease and zosteriform spread was observed in immunized animals and there was no encephalitis compared with 95% encephalitis in mock-immunized mice. The potential of such mucosal adjuvants for use in human vaccines against pathogens such as HSV-1 is discussed.
|
Authors | C M Richards, A T Aman, T R Hirst, T J Hill, N A Williams |
Journal | Journal of virology
(J Virol)
Vol. 75
Issue 4
Pg. 1664-71
(Feb 2001)
ISSN: 0022-538X [Print] United States |
PMID | 11160664
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adjuvants, Immunologic
- Antibodies, Viral
- Bacterial Toxins
- Enterotoxins
- Escherichia coli Proteins
- Recombinant Proteins
- Viral Envelope Proteins
- Cholera Toxin
- heat-labile enterotoxin, E coli
|
Topics |
- Adjuvants, Immunologic
- Administration, Intranasal
- Animals
- Antibodies, Viral
(blood)
- Bacterial Toxins
(genetics, immunology)
- Cholera Toxin
(genetics, immunology)
- Enterotoxins
(genetics, immunology)
- Escherichia coli
(metabolism)
- Escherichia coli Proteins
- Female
- Herpesvirus 1, Human
(immunology)
- Immunity, Mucosal
- Immunization
- Keratitis, Herpetic
(immunology)
- Mice
- Recombinant Proteins
(immunology)
- Viral Envelope Proteins
(immunology)
|